Diagnostic and Defense Technology Analysts, Inc. debuts AI product AstraLaunch

AstraLaunch helps align research, patented or not, with the market early in development.

Astra Launch
AstraLaunch

CHULA VISTA, Calif., - Diagnostic and Defense Technology Analysts, Inc. (DTA) recently announced its new artificial intelligence (AI) technology, AstraLaunch, and is suitable for technology transfer offices, accelerators and industry. AstraLaunch is for anyone that needs to prioritize the commercialization potential of a technology.

AstraLaunch is designed to prioritize the commercialization potential of a technology using scientific metrics and AI for attaining real time market intelligence. In addition, AstraLaunch will leverage prior NASA work to help determine if a technology has an insertion point into the NASA commercialization roadmap. AstraLaunch helps align research, patented or not, with the market early in development.

Carey Adolfsson, CEO of DTA shares, “The MVP we have developed proves we can take any technology or research project and match it with a government need. We are first working within the NASA framework, but will continue to build other government frameworks into the system. Thereby creating an effective and risk mitigating factor into the billions of dollars government spends on R&D.”

For more information, please visit https://astralaunch.com/

More in Resources